Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.55 |
| ▸ | GAA | P10253 | 4/20 | 0.55 |
| ▸ | PKM | P14618 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | HTT | P42858 | 3/20 | 0.55 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.47 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.46 |
| ▸ | ALPL | P05186 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | ALPI | P09923 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20865069 | 1.00 | MAPT (0.55) | MAPTGAAPKMLMNAHTT | |
| SCHEMBL20865076 | 0.89 | SMN1; SMN2 (0.50) | MAPTGAAPKMLMNAHTT | |
| SCHEMBL6757226 | 0.75 | MAPK1 (0.66) | GAAPKMHTTCYP3A4CYP2D6 | |
| SCHEMBL13050694 | 0.74 | CYP3A4 (0.64) | GAAPKMCYP3A4CYP2D6CYP2C9 | |
| SCHEMBL2680248 | 0.74 | CYP3A4 (0.64) | GAAPKMCYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4113303 | 0.74 | DDAH1 (0.65) | MAPTGAAPKMCYP3A4CYP2D6 | |
| SCHEMBL20865041 | 0.73 | TAAR1 (0.41) | — | |
| SCHEMBL29783451 | 0.73 | TAAR1 (0.41) | — | |
| SCHEMBL22304368 | 0.72 | NPC1 (0.51) | GAALMNAHTTMAPK1TSHR | |
| SCHEMBL5539720 | 0.72 | SMN1; SMN2 (0.53) | MAPTGAAPKMLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11389385-B2 | Resorcinol derivatives for their cosmetic use | L'OREAL (FR) | 2022-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11389385-B2 | Resorcinol derivatives for their cosmetic use | KRT18, RBP4, RARA | MAPT 805/4885GAA 502/4885PKM 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.